INTS — INTENSITY THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — |
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal quarter end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -1.13 | — | -0.99 | -1.28 | 2 | −2 |
| Mar 2027 | -0.36 | — | -0.36 | -0.36 | 1 | −1 |
| Jun 2027 | -0.38 | — | -0.38 | -0.38 | 1 | — |
| Sep 2027 | -0.43 | — | -0.43 | -0.43 | 1 | — |
| Dec 2027 | -0.49 | — | -0.49 | -0.49 | 1 | — |
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -4.32 | — | -4.15 | -4.48 | 2 | −2 |
| Dec 2027 | -2.37 | — | -1.67 | -3.06 | 2 | −2 |
| Dec 2028 | -4.05 | — | -0.77 | -7.32 | 2 | — |
| Dec 2029 | 3.58 | 0.7× | 8.09 | -0.94 | 2 | +1 |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 15 SEC-registered investment managers reported holding INTS (INTENSITY THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $2.94M across 873.52K shares. That is +33.5% by share count (+216.65K shares) versus the previous quarter, while reported value moved +9.8%. Ownership is concentrated: the five largest holders account for 92.7% of reported value and the top ten for 99.9%.
Compared with the prior quarter, 2 opened new positions, 3 added to existing stakes, 5 trimmed, 5 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of INTENSITY THERAPEUTICS INC (INTS) include Kingsbury Capital Investment Advisors LLC, KMT WEALTH MANAGEMENT, LLC, ARMISTICE CAPITAL, LLC, ranked by reported 13F value among the 62 institutional holders on this page.
INTS is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 15 | 873.52K | $2.94M | +33.5% |
| Q2 2026 | 18 | 1.19M | $4.88M | +261.0% |
| Q1 2026 | 14 | 180.28K | $1.06M | -95.3% |
| Q4 2025 | 34 | 3.91M | $1.58M | +14.9% |
| Q3 2025 | 25 | 2.96M | $719.97K | +51.2% |
| Q2 2025 | 25 | 1.96M | $601.49K | +5.2% |
| Q1 2025 | 21 | 2.59M | $5.10M | -5.7% |
| Q4 2024 | 19 | 2.70M | $4.76M | -8.1% |
Over the 8 quarters shown, institutional share counts decreased 68% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2026 (+261.0%).
Top Institutional Holders (Q3 2026) — 15 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 706.52K | $2.38M | 2.25% | Add | |
| 29.22K | $98.47K | 0.01% | Add | |
| 26.57K | $89.54K | 0.00% | Hold | |
| 25.00K | $84.25K | 0.06% | Hold | |
| 22.24K | $74.94K | 0.00% | Reduce | |
| 21.07K | $70.99K | 0.00% | Add | |
| 15.80K | $53.00K | 0.02% | Reduce | |
| 14.04K | $47.31K | 0.00% | Reduce | |
| 10.65K | $35.88K | 0.00% | New | |
| 1.15K | $3.87K | 0.00% | Hold | |
| 1.00K | $3.38K | 0.00% | Reduce | |
| 234 | $789 | 0.00% | New | |
| 26 | $88 | 0.00% | Reduce | |
| 6 | $20 | 0.00% | Hold | |
| 1 | $3 | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 18 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 496.49K | $2.04M | 1.72% | Add | |
| 496.49K | $2.04M | 0.66% | New | |
| 26.72K | $109.56K | 0.01% | Add | |
| 26.57K | $108.93K | 0.00% | Add | |
| 26.01K | $106.62K | 0.00% | Hold | |
| 25.00K | $102.50K | 0.08% | Hold | |
| 22.79K | $93.43K | 0.00% | New | |
| 22.79K | $93.43K | 0.00% | Reduce | |
| 22.00K | $90.00K | 0.04% | New | |
| 14.12K | $57.88K | 0.00% | Hold | |
| 9.12K | $37.40K | 0.00% | Hold | |
| 1.98K | $8.13K | 0.00% | Add | |
| 1.15K | $4.71K | 0.00% | Hold | |
| 200 | $820 | 0.00% | Hold | |
| 42 | $172 | 0.00% | New | |
| 20 | $82 | 0.00% | Hold | |
| 6 | $25 | 0.00% | New | |
| 1 | $4 | 0.00% | Reduce |
Q1 2026 — 14 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 38.05K | $223.76K | 0.21% | New | |
| 26.02K | $152.99K | 0.00% | Reduce | |
| 26.01K | $152.91K | 0.00% | Reduce | |
| 25.00K | $147.00K | 0.14% | New | |
| 23.29K | $136.97K | 0.01% | Reduce | |
| 16.84K | $99.03K | 0.00% | New | |
| 14.12K | $83.01K | 0.00% | Reduce | |
| 9.12K | $53.63K | 0.00% | New | |
| 1.15K | $6.75K | 0.00% | Reduce | |
| 200 | $1.18K | 0.00% | New | |
| 200 | $1.18K | 0.00% | New | |
| 192 | $1.13K | 0.00% | Reduce | |
| 67 | $394 | 0.00% | Reduce | |
| 20 | $118 | 0.00% | Reduce |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 649.08K | $266.12K | 0.00% | Add | |
| 650.15K | $244.20K | 0.00% | Reduce | |
| 495.91K | $203.42K | 0.02% | Add | |
| 460.25K | $188.79K | 0.00% | Add | |
| 251.00K | $102.96K | 0.00% | Add | |
| 153.45K | $62.94K | 0.01% | New | |
| 143.14K | $58.71K | 0.00% | New | |
| 136.20K | $55.87K | 0.00% | Add | |
| 130.00K | $53.33K | 0.00% | Hold | |
| 100.00K | $41.02K | 0.00% | New | |
| 77.38K | $31.74K | 0.00% | Add | |
| 75.54K | $30.99K | 0.00% | Add | |
| 69.00K | $28.10K | 0.00% | Add | |
| 62.76K | $25.74K | 0.00% | New | |
| 56.43K | $23.15K | 0.00% | Reduce | |
| 50.48K | $20.71K | 0.00% | Add | |
| 48.72K | $20.00K | 0.00% | Add | |
| 41.35K | $16.96K | 0.00% | Add | |
| 34.83K | $14.29K | 0.00% | Add | |
| 31.80K | $13.04K | 0.00% | Hold | |
| 30.19K | $12.38K | 0.00% | Reduce | |
| 25.40K | $10.41K | 0.00% | Reduce | |
| 25.00K | $10.26K | 0.00% | New | |
| 21.53K | $8.83K | 0.00% | Add | |
| 17.42K | $6.52K | 0.00% | Hold |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 976.80K | $239.71K | 0.00% | Hold | |
| 481.18K | $116.78K | 0.03% | Add | |
| 258.89K | $62.83K | 0.00% | Add | |
| 255.93K | $62.19K | 0.00% | Add | |
| 200.00K | $48.54K | 0.00% | Add | |
| 136.23K | $33.10K | 0.00% | Add | |
| 130.07K | $31.57K | 0.00% | Hold | |
| 69.17K | $16.79K | 0.00% | Hold | |
| 60.00K | $14.56K | 0.00% | Reduce | |
| 54.38K | $13.20K | 0.00% | Add | |
| 47.48K | $11.52K | 0.00% | New | |
| 44.58K | $10.82K | 0.00% | New | |
| 37.80K | $9.18K | 0.00% | Hold | |
| 31.80K | $7.72K | 0.00% | Hold | |
| 24.73K | $6.00K | 0.00% | New | |
| 25.98K | $6.00K | 0.00% | Add | |
| 20.00K | $4.85K | 0.00% | New | |
| 19.22K | $4.66K | 0.00% | Add | |
| 18.45K | $4.48K | 0.00% | New | |
| 17.42K | $4.23K | 0.00% | Hold | |
| 16.69K | $4.05K | 0.00% | Add | |
| 14.50K | $3.52K | 0.00% | Hold | |
| 14.02K | $3.40K | 0.00% | Hold | |
| 620 | $150 | 0.00% | Add | |
| 500 | $121 | 0.00% | Hold |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 976.80K | $299.88K | 0.01% | Hold | |
| 199.32K | $61.19K | 0.01% | Add | |
| 130.07K | $39.93K | 0.00% | Hold | |
| 110.00K | $33.77K | 0.00% | Add | |
| 72.81K | $22.36K | 0.00% | Reduce | |
| 69.17K | $21.23K | 0.00% | Add | |
| 68.40K | $21.00K | 0.01% | New | |
| 44.90K | $13.78K | 0.00% | New | |
| 40.59K | $12.46K | 0.00% | Reduce | |
| 37.80K | $11.61K | 0.00% | Hold | |
| 31.80K | $9.76K | 0.00% | Hold | |
| 24.55K | $7.54K | 0.00% | New | |
| 24.90K | $7.00K | 0.00% | New | |
| 17.42K | $5.35K | 0.00% | Hold | |
| 16.52K | $5.07K | 0.00% | Add | |
| 16.03K | $4.92K | 0.00% | New | |
| 15.00K | $4.61K | 0.00% | New | |
| 14.50K | $4.45K | 0.00% | Hold | |
| 14.02K | $4.30K | 0.00% | Hold | |
| 13.49K | $4.14K | 0.00% | Add | |
| 13.70K | $4.00K | 0.00% | New | |
| 9.23K | $2.83K | 0.00% | Add | |
| 500 | $154 | 0.00% | Hold | |
| 388 | $119 | 0.00% | Add | |
| 100 | $31 | 0.00% | New |
New Positions (Q3 2026)
- STATE STREET CORP 10.65K sh · $35.88K
- Citigroup Inc 234 sh · $789
Fully Exited (vs previous quarter)
- KMT WEALTH MANAGEMENT, LLC sold 496.49K sh · $2.04M
- SAPIENT CAPITAL LLC sold 26.01K sh · $106.62K
- GEODE CAPITAL MANAGEMENT, LLC sold 22.79K sh · $93.43K
- OSAIC HOLDINGS, INC. sold 200 sh · $820
- Morgan Stanley sold 20 sh · $82
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kingsbury Capital Investment Advisors LLC | 706.52K | 496.49K | 38.05K | — | — | — | — | — | — | — | — | — | — |
| Rothschild Wealth LLC | 29.22K | 26.72K | 23.29K | 495.91K | 481.18K | 199.32K | 27.30K | — | 18.92K | 13.34K | 28.81K | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 26.57K | 26.57K | 16.84K | — | — | — | — | — | — | — | — | — | — |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 25.00K | 25.00K | 25.00K | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 22.24K | 22.79K | 26.02K | 460.25K | 258.89K | 72.81K | 77.48K | 64.35K | 64.35K | 47.62K | 47.62K | 45.36K | 23.07K |
| VANGUARD FIDUCIARY TRUST CO | 21.07K | 9.12K | 9.12K | — | — | — | — | — | — | — | — | — | — |
| FNY Investment Advisers, LLC | 15.80K | 22.00K | — | — | — | — | — | — | — | — | — | — | — |
| Mesirow Financial Investment Management, Inc. | 14.04K | 14.12K | 14.12K | 251.00K | 200.00K | 110.00K | 40.00K | 20.00K | 44.18K | 44.18K | 44.18K | 34.18K | — |
| STATE STREET CORP | 10.65K | — | — | 136.20K | 14.50K | 14.50K | 14.50K | 14.50K | 14.50K | 14.50K | 14.50K | 14.50K | — |
| NewEdge Advisors, LLC | 1.15K | 1.15K | 1.15K | 25.00K | — | — | — | — | — | — | — | — | — |
| Tower Research Capital LLC (TRC) | 1.00K | 1.98K | 67 | 21.53K | 16.69K | 13.49K | 2.38K | 2.65K | 1.17K | 2.35K | 7.03K | — | 1.03K |
| Citigroup Inc | 234 | — | — | 88 | 44.58K | — | — | — | — | — | — | — | — |
| BARCLAYS PLC | 26 | 42 | — | — | — | — | — | — | — | — | — | — | — |
| Caitong International Asset Management Co., Ltd | 6 | 6 | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 1 | 1 | 192 | 25.40K | 136.23K | 9.23K | 3.10K | 3.02K | 20.61K | 3.32K | 3.01K | 500 | — |
| SAPIENT CAPITAL LLC | — | 26.01K | 26.01K | 650.15K | 976.80K | 976.80K | 976.80K | 942.84K | 1.01M | 1.01M | 1.01M | 200.00K | — |
| KMT WEALTH MANAGEMENT, LLC | — | 496.49K | — | — | — | — | — | — | — | — | — | — | — |
| ARMISTICE CAPITAL, LLC | — | — | — | — | — | — | 872.55K | 1.13M | — | — | — | — | — |
| Vanguard Group | — | — | — | 649.08K | 255.93K | 40.59K | 230.66K | 208.89K | 208.89K | 204.97K | 177.19K | 83.07K | — |
| BROWN ADVISORY INC | — | — | — | 130.00K | 130.07K | 130.07K | 130.07K | 130.07K | 148.11K | 157.53K | 157.53K | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold INTS?
As of 2026-Q3, 15 institutional funds reported holding INTS (INTENSITY THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $2.94M.
How many shares of INTS do institutions own?
13F filers reported 873.52K shares of INTS, worth $2.94M in aggregate at the end of 2026-Q3.
Is institutional ownership of INTS rising or falling?
Share counts moved +33.5% versus the prior quarter — accumulation.
Who are the top institutional holders of INTS?
The largest 13F holders are Kingsbury Capital Investment Advisors LLC, KMT WEALTH MANAGEMENT, LLC, ARMISTICE CAPITAL, LLC, HOHIMER WEALTH MANAGEMENT, LLC, Vanguard Group; the top 25 are ranked at the top of this page.
Who are the major shareholders of INTENSITY THERAPEUTICS INC?
The major shareholders of INTENSITY THERAPEUTICS INC (INTS) by reported 13F value are Kingsbury Capital Investment Advisors LLC, KMT WEALTH MANAGEMENT, LLC, ARMISTICE CAPITAL, LLC, HOHIMER WEALTH MANAGEMENT, LLC, Vanguard Group, among 62 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.